Epidemiology of atrial fibrillation in Turkey: Preliminary results of the multicenter AFTER study

Turk Kardiyoloji Dernegi Arsivi

Volumn 41, Issue 2, 2013, Pages 99-104

  Ertaş, Faruk ^a   Kaya, Hasan ^a   Kaya, Zekeriya ^b   Bulur, Serkan ^c   Köse, Nuri ^d   Gül, Mehmet ^e   Eren, Nihan Kahya ^f   Çaǧliyan, Çaǧlar Emre ^g   Köroǧlu, Bayram ^h   Vatan, Bülent ⁱ   Acar, Göksel ^j   Yüksel, Murat ^k   Bilik, Mehmet Zihni ^a   Gedik, Selçuk ^l   Şimşek, Ziya ^m   Akil, Mehmet Ata ^a   Yilmaz, Rüstern ⁿ   Oylumlu, Mustafa ^a   Aribaş, Alpay ^o   Yildiz, Abdulkadir ^a   Aydin, Mesut ^a   Yeter, Ekrem ^p   Kanadaşi, Mehmet ^q   Ergene, Oktay ^f   Özhan, Hakan ^d   Ülgen, Mehmet Siddik ^a   more..

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b HARRAN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c DUZCE UNIVERSITY   (Turkey)

^d Dept of Cardiology Mugla Yücelen Hospital   (Turkey)

^e Mehmet Akif Ersoy Heart Hospital   (Turkey)

^f ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^g Adana Numune Teaching and Research Hospital   (Turkey)

^h DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

ⁱ SAKARYA UNIVERSITY   (Turkey)

^j Kartal Kosuyolu Training and Research Hospital   (Turkey)

^k MALATYA STATE HOSPITAL   (Turkey)

^l ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^m ATATURK UNIVERSITY   (Turkey)

ⁿ Gazi State Hospital Samsun   (Turkey)

^o NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^p YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

^q CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

more..

Author keywords

Atrial fibrillation epidemiology etiology; Chronic disease; Female; Hypertension complications; Turkey epidemiology

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; POPULATION RESEARCH; PROSPECTIVE STUDY; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; TURKEY (REPUBLIC); ADULT; ATRIAL FIBRILLATION; BLEEDING; CLINICAL TRIAL; COMPLICATION; ELECTROCARDIOGRAPHY; MIDDLE AGED; RISK FACTOR; TURKEY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HEMORRHAGE; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOEMBOLISM; TURKEY; WARFARIN; YOUNG ADULT;

EID: 84876704641     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2013.18488     Document Type: Article

References (18)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5. (Pubitemid 32424106)
2. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
3. Ertaş F, Duygu H, Acet H, Eren NK, Nazli C, Ergene AO. Oral anticoagulant use in patients with atrial fibrillation. Turk Kardiyol Dern Ars 2009;37:161-7.
4. Karaçaǧlar E, Atar I, Yetiş B, Corut H, Ersoy B, Yilmaz K, et al. The frequency of embolic risk factors and adequacy of anti-embolic treatment in patients with atrial fibrillation: a single tertiary center experience. Anadolu Kardiyol Derg 2012;12:384-90.
5. Ertaş F, Kaya H, Atilgan ZA, Elbey MA, Aydin M, Akil MA, et al. Predictors of warfarin use in patients with non-valvular atrial fibrillation who presented to the cardiology outpatient clinic of a tertiary hospital in Turkey: an observational study. Turk J Med Sci 2012;42:1172-9.
6. Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H; J-RHYTHM Registry Investigators. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Registry. Circ J 2011;75:1328-33.
7. Shin HW, Kim YN, Bae HJ, Lee HM, Cho HO, Cho YK, et al. Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation. Korean Circ J 2012;42:113-7.
8. Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int 2012;109:293-9.
9. Waldo AL, Becker RC, Tapson VF, Colgan KJ; NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 2005;46:1729-36. (Pubitemid 41531631)
10. Ertaş F, Kaya H, Yüksel M, Soydinç MS, Alan S, Ulgen MS. Atrial Fibrillation in Turkey: Epidemiologic Registry (AFTER) study design. Anadolu Kardiyol Derg 2013 Feb 6. [Epub ahead of print]
11. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263-72.
12. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 2009;11:423-34.
13. Uyarel H, Onat A, Yüksel H, Can G, Ordu S, Dursunoǧlu D. Incidence, prevalence, and mortality estimates for chronic atrial fibrillation in Turkish adults. Turk Kardiyol Dern Ars 2008;36:214-22.
14. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6. (Pubitemid 39319000)
15. Bover R, Pérez-Gómez F, Maluenda MP, Asenjo S, Pérez-Saldaña R, Igea A, et al. Long-term follow-up of atrial fibrillation patients in the NASPEAF study. Prospective evaluation of different antiplatelet treatments. Rev Esp Cardiol 2009;62:992-1000.
16. Nieuwlaat R, Capucci A, Camm AJ, Olsson SB, Andresen D, Davies DW, et al. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26:2422-34. (Pubitemid 41552972)
17. Baczek VL, Chen WT, Kluger J, Coleman CI. Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis. BMC Fam Pract 2012;13:5.
18. van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 2006;129:1155-66.